Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE

UnknownOBSERVATIONAL
Enrollment

245

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
OTHER

Clinical assessment

All participants will be invited to attend their local research facility to undergo a physical and questionnaire assessment as well as an MRI. Assessments include: Expanded Disability Status Scale, 9-Hole Peg Test, MRI scan, Patient Reported Outcome Measures (MSIS-29, neuroQOL and PROMIS), Brief International Cognitive Assessment for MS)

Trial Locations (1)

G51 4TF

Clinical Research Facility, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

NHS Greater Glasgow and Clyde

OTHER